- Conditions
- Gastroesophageal Reflux
- Interventions
- pantoprazole
- Drug
- Lead sponsor
- University of Louisville
- Other
- Eligibility
- 28 Weeks to 11 Months
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–30
of 30
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Dysphagia of Newborn
- Interventions
- Pacifier-Activated Lullaby (PAL) Therapy
- Device
- Lead sponsor
- Nemours Children's Clinic
- Other
- Eligibility
- 34 Weeks to 36 Weeks
- Enrollment
- 46 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2027
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Gastroesophageal Reflux
- Interventions
- Rabeprazole sodium
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- Up to 44 Weeks
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 10
- States / cities
- Orange, California • Washington D.C., District of Columbia • Augusta, Georgia + 7 more
- Conditions
- Gastroesophageal Reflux Disease, Bronchopulmonary Dysplasia
- Interventions
- Fundoplication
- Procedure
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 24 Weeks to 1 Year
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Open Label Run In Esomeprazole, Double Blind Esomeprazole, Double Blind Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 1 Month to 11 Months
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 14
- States / cities
- Phoenix, Arizona • Atlanta, Georgia • Park Ridge, Illinois + 11 more
- Conditions
- Gastroesophageal Reflux, Presumed Sepsis, Patent Ductus Arteriosus, Chronic Lung Disease, Neurodevelopmental Impairment
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- Up to 5 Days
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Durham, North Carolina